Invesco
TCRT icon

Invesco’s Alaunos Therapeutics TCRT Stock Holding History

Invesco’s Portfolio TCRT Stock Details TCRT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-614
Closed -$60K – 4142
2022
Q1 		$60K Sell
614
-19
-3% -$2.44K ﹤0.01% 3914
2021
Q4 		$104K Sell
633
-51
-7% -$11.2K ﹤0.01% 3897
2021
Q3 		$188K Buy
684
+110
+19% +$33.6K ﹤0.01% 3823
2021
Q2 		$227K Buy
574
+230
+67% +$107K ﹤0.01% 3747
2021
Q1 		$186K Buy
344
+65
+23% +$40.5K ﹤0.01% 3691
2020
Q4 		$105K Buy
279
+200
+253% +$79.5K ﹤0.01% 3635
2020
Q3 		$30K Buy
79
+4
+5% +$1.77K ﹤0.01% 3613
2020
Q2 		$37K Buy
75
+1
+1% +$446 ﹤0.01% 3622
2020
Q1 		$27K Sell
74
-322
-81% -$167K ﹤0.01% 3619
2019
Q4 		$281K Buy
+396
New +$273K ﹤0.01% 3442
2019
Q3 		– Sell
-2,976
Closed -$2.6M – 3720
2019
Q2 		$2.6M Buy
+2,976
New +$2.05M ﹤0.01% 2561
2017
Q2 		– Sell
-7,000
Closed -$6.66M – 3722
2017
Q1 		$6.66M Buy
7,000
+8
+0.1% +$7.45K ﹤0.01% 1791
2016
Q4 		$5.61M Buy
6,992
+6,891
+6,823% +$6.21M ﹤0.01% 1910
2016
Q3 		$86K Sell
101
-6,348
-98% -$5.1M ﹤0.01% 3599
2016
Q2 		$5.31M Buy
6,449
+624
+11% +$679K ﹤0.01% 1881
2016
Q1 		$6.48M Buy
+5,825
New +$5.96M ﹤0.01% 1667
2015
Q3 		– Sell
-1,560
Closed -$2.81M – 3978
2015
Q2 		$2.81M Sell
1,560
-677
-30% -$1.05M ﹤0.01% 2404
2015
Q1 		$3.62M Buy
+2,237
New +$3.32M ﹤0.01% 2205
2014
Q2 		– Sell
-4,816
Closed -$3.31M – 4088
2014
Q1 		$3.31M Buy
+4,816
New +$3.23M ﹤0.01% 2226

Other funds holding TCRT

MP
MSD Partners New York $82.3M AUM 15.13% 1-Year Est. Return
DCM
Discovery Capital Management South Norwalk, Connecticut $1.92B AUM 218.96% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Invesco's TCRT Position: Q2 2022 in Review

Invesco sold out of Alaunos Therapeutics (TCRT) in Q2 2022, closing a stake of 614 shares — an estimated $60K sold.

Invesco first reported a position in TCRT in Q1 2014 and held it in 19 quarters. The position peaked at $6.66M in Q1 2017. 124 funds tracked by Wall St. Rank hold TCRT as of Q2 2022.

  • Invesco reported no remaining Alaunos Therapeutics position as of Q2 2022 after selling out during the quarter.
  • Invesco sold 614 Alaunos Therapeutics shares in Q2 2022, an estimated $60K.
  • Invesco first reported a position in Alaunos Therapeutics in Q1 2014 and held it in 19 quarters.
  • Invesco's Alaunos Therapeutics position peaked at $6.66M in Q1 2017.
  • 124 funds tracked by Wall St. Rank held Alaunos Therapeutics as of Q2 2022.

Based on Invesco's 13F filing for Q2 2022, filed 15 Aug 2022.